Abstract

BackgroundAs stem cells of the early embryo mature and differentiate into all tissues, the mitochondrial complement undergoes dramatic functional improvement. Mitochondrial activity is low to minimize generation of DNA-damaging reactive oxygen species during pre-implantation development and increases following implantation and differentiation to meet higher metabolic demands. It has recently been reported that when the stem cell type known as induced pluripotent stem cells (IPSCs) are re-differentiated for several weeks in vitro, the mitochondrial complement progressively re-acquires properties approximating input fibroblasts, suggesting that despite the observation that IPSC conversion “resets” some parameters of cellular aging such as telomere length, it may have little impact on other age-affected cellular systems such as mitochondria in IPSC-derived cells.Methodology/Principal FindingsWe have examined the properties of mitochondria in two fibroblast lines, corresponding IPSCs, and fibroblasts re-derived from IPSCs using biochemical methods and electron microscopy, and found a dramatic improvement in the quality and function of the mitochondrial complement of the re-derived fibroblasts compared to input fibroblasts. This observation likely stems from two aspects of our experimental design: 1) that the input cell lines used were of advanced cellular age and contained an inefficient mitochondrial complement, and 2) the re-derived fibroblasts were produced using an extensive differentiation regimen that may more closely mimic the degree of growth and maturation found in a developing mammal.Conclusions/SignificanceThese results — coupled with earlier data from our laboratory — suggest that IPSC conversion not only resets the “biological clock”, but can also rejuvenate the energetic capacity of derived cells.

Highlights

  • Induced pluripotent stem cells (IPSCs) are emerging as an important new tool to model human disease with potential to be used one day in the treatment of these same disorders

  • Mitochondria were analyzed in two human primary cell lines at three phenotypic stages: fibroblasts, induced pluripotent stem cells (IPSCs), and fibroblasts derived from IPSC teratomas

  • No IPSCderived cell is likely to be phenotypically identical to the parental input cell, we believe that TER cells represent the best approximation possible

Read more

Summary

Introduction

Induced pluripotent stem cells (IPSCs) are emerging as an important new tool to model human disease with potential to be used one day in the treatment of these same disorders. We have recently described a matched set of cell lines derived from two fibroblast (FIB) lines — FIBA and FIBB – designed to answer questions regarding the ‘‘before and after’’ specifics of IPSC conversion[7] Both FIBA and FIBB display average telomere lengths that are approximately equivalent (10.25 Kb and 10.76 Kb respectively) even though both lines were derived from individuals of very different ages (EW16 and 70 yrs, respectively). Despite the fact that both lines were relatively old in cellular terms, both yielded multiple IPSC lines displaying all of the hallmarks of human ESCs, and displayed an average telomere elongation of .40% (10.5 Kb to 15.4 Kb) compared to input cells[7] Together, these results suggested that reprogramming restored at least one key indicator of cellular age – telomere length – following adoption of the IPSC phenotype. It has recently been reported that when the stem cell type known as induced pluripotent stem cells (IPSCs) are re-differentiated for several weeks in vitro, the mitochondrial complement progressively re-acquires properties approximating input fibroblasts, suggesting that despite the observation that IPSC conversion ‘‘resets’’ some parameters of cellular aging such as telomere length, it may have little impact on other age-affected cellular systems such as mitochondria in IPSC-derived cells

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.